The store will not work correctly when cookies are disabled.
(2-Methylphenyl)(3,9-diazaspiro[5.5]undecan-3-yl)methanone
ID: ALA5208168
PubChem CID: 120489762
Max Phase: Preclinical
Molecular Formula: C17H24N2O
Molecular Weight: 272.39
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccccc1C(=O)N1CCC2(CCNCC2)CC1
Standard InChI: InChI=1S/C17H24N2O/c1-14-4-2-3-5-15(14)16(20)19-12-8-17(9-13-19)6-10-18-11-7-17/h2-5,18H,6-13H2,1H3
Standard InChI Key: GKHRXUXSWQBUOH-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
26.5360 -2.9951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2511 -3.4067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9632 -2.9991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9664 -2.1742 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.2514 -1.7585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5331 -2.1719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1102 -2.9951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1102 -3.8224 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.8247 -4.2298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5393 -3.8224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8247 -2.5753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6803 -1.7604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6824 -0.9330 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.3905 -2.1720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3889 -2.9962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1007 -3.4080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8146 -2.9966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8123 -2.1693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0999 -1.7613 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0979 -0.9382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
7 8 1 0
7 11 1 0
8 9 1 0
9 10 1 0
10 1 1 0
1 11 1 0
4 12 1 0
12 13 2 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
12 14 1 0
19 20 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 272.39 | Molecular Weight (Monoisotopic): 272.1889 | AlogP: 2.60 | #Rotatable Bonds: 1 |
Polar Surface Area: 32.34 | Molecular Species: BASE | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 10.33 | CX LogP: 2.08 | CX LogD: -0.68 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.85 | Np Likeness Score: -0.93 |
References
1. Bavo F, de-Jong H, Petersen J, Falk-Petersen CB, Löffler R, Sparrow E, Rostrup F, Eliasen JN, Wilhelmsen KS, Barslund K, Bundgaard C, Nielsen B, Kristiansen U, Wellendorph P, Bogdanov Y, Frølund B.. (2021) Structure-Activity Studies of 3,9-Diazaspiro[5.5]undecane-Based γ-Aminobutyric Acid Type A Receptor Antagonists with Immunomodulatory Effect., 64 (24.0): [PMID:34908407] [10.1021/acs.jmedchem.1c00290] |